Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Selecta Biosciences (NQ: SELB )

4.180 USD -0.100 (-2.34%)
Official Closing Price Updated: 7:37 PM EDT, Apr 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 489,600
Open 4.250
Bid (Size) 4.180 (225)
Ask (Size) 4.260 (1)
Prev. Close 4.280
Today's Range 4.150 - 4.260
52wk Range 1.470 - 5.700
Shares Outstanding 22,349,840
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Selecta Biosciences to Participate at the 20th Annual Needham Healthcare Conference
From GlobeNewswire News Releases
Best Penny Stocks On Robinhood To Watch This Week If You Like Biotech
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed

Performance

YTD
+39.80%
+39.80%
1 Month
+7.18%
+7.18%
3 Month
+28.22%
+28.22%
6 Month
+104.90%
+104.90%
1 Year
+59.54%
+59.54%

More News

Read More
Hot Penny Stocks To Buy According To 4 Analysts & Targets Up To $13
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Selecta Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results
From GlobeNewswire News Releases
4 Penny Stocks Analysts Say To Buy With Targets Of Up To 360%
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Selecta Biosciences to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2020 Financial Results and Recent Operational Highlights
From GlobeNewswire News Releases
Selecta Biosciences to Participate in the H.C. Wainwright Global Life Sciences Conference
From GlobeNewswire News Releases
Selecta Biosciences Announces Science Advances Publication Highlighting Potential Potency and Durability Benefits of ImmTOR™ in Gene Therapy
From GlobeNewswire News Releases
Selecta Biosciences and AskBio Initiate First-in-Human Dose-Escalation Study to Evaluate ImmTOR™ in Gene Therapy
From GlobeNewswire News Releases
Selecta Biosciences and AskBio Initiate First-in-Human Dose-Escalation Study to Evaluate ImmTOR™ in Gene Therapy
From PR Newswire
Selecta Biosciences to Present at the SVB Leerink 10th Annual Global Healthcare Conference
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.